http://www.unboundmedicine.com/medline/ebm/research/rifabutinUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19915104/full_citation/Revival_and_emended_description_of_'Mycobacterium_paraffinicum'__Davis_Chase_and_Raymond_1956__as_Mycobacterium_paraffinicum__ex_Davis_Chase_and_Raymond_1956__sp__nov__nom__rev_Toney NC, Adekambi T, Toney S, et al. 
Revival and emended description of 'Mycobacterium paraffinicum' (Davis, Chase and Raymond 1956) as Mycobacterium paraffinicum (ex Davis, Chase and Raymond 1956) sp. nov., nom. rev. [JOURNAL ARTICLE]
Int J Syst Evol Microbiol 2009 Nov 13.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19897506/full_citation/Factors_influencing_lopinavir_and_atazanavir_plasma_concentration_Stöhr W, Back D, Dunn D, et al. 
Factors influencing lopinavir and atazanavir plasma concentration. [JOURNAL ARTICLE]
J Antimicrob Chemother 2009 Nov 6.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19860266/full_citation/[Cross_resistance_between_rifampicin_and_rifabutin_among_multi_drug_resistant_Mycobacterium_tuberculosis_strains]Chikamatsu K, Mizuno K, Yamada H, et al. 
[Cross-resistance between rifampicin and rifabutin among multi-drug resistant Mycobacterium tuberculosis strains] [English Abstract, Journal Article]
Kekkaku 2009 Sep; 84(9):631-3.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19846355/full_citation/Efficacy_of_four_different_moxifloxacin_based_triple_therapies_for_first_line_H__pylori_treatment_Sacco F, Spezzaferro M, Amitrano M, et al. 
Efficacy of four different moxifloxacin-based triple therapies for first-line H. pylori treatment. [JOURNAL ARTICLE]
Dig Liver Dis 2009 Oct 19.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19809428/full_citation/Inhibition_of_constitutive_and_cxc_chemokine_induced_NF_kappaB_activity_potentiates_ansamycin_based_HSP90_inhibitor_cytotoxicity_in_castrate_resistant_prostate_cancer_cells_Seaton A, Maxwell PJ, Hill A, et al. 
Inhibition of constitutive and cxc-chemokine-induced NF-kappaB activity potentiates ansamycin-based HSP90-inhibitor cytotoxicity in castrate-resistant prostate cancer cells. [JOURNAL ARTICLE]
Br J Cancer 2009 Oct 6.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19807276/full_citation/Pharmacokinetic_Evaluation_of_Rifabutin_in_Combination_with_Lopinavir_Ritonavir_in_Patients_with_HIV_Infection_and_Active_Tuberculosis_Boulanger C, Hollender E, Farrell K, et al. 
Pharmacokinetic Evaluation of Rifabutin in Combination with Lopinavir-Ritonavir in Patients with HIV Infection and Active Tuberculosis. [JOURNAL ARTICLE]
Clin Infect Dis 2009 Oct 6.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19788600/full_citation/Second_Asia_Pacific_Consensus_Guidelines_for_Helicobacter_pylori_infection_Fock KM, Katelaris P, Sugano K, et al. 
Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. [Journal Article]
J Gastroenterol Hepatol 2009 Oct; 24(10):1587-600.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19773678/full_citation/ESTHETIC_OUTCOME_OF_SURGICAL_EXCISION_VERSUS_ANTIBIOTIC_THERAPY_FOR_NONTUBERCULOUS_MYCOBACTERIAL_CERVICOFACIAL_LYMPHADENITIS_IN_CHILDREN_Lindeboom JA, Lindeboom R, Bruijnesteijn van Coppenraet ES, et al. 
ESTHETIC OUTCOME OF SURGICAL EXCISION VERSUS ANTIBIOTIC THERAPY FOR NONTUBERCULOUS MYCOBACTERIAL CERVICOFACIAL LYMPHADENITIS IN CHILDREN. [JOURNAL ARTICLE]
Pediatr Infect Dis J 2009 Sep 19.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19770461/full_citation/Acute_generalized_exanthematous_pustulosis_caused_by_rifabutin_Chen CP, Hsu YH, Hong SJ 
Acute generalized exanthematous pustulosis caused by rifabutin. [Case Reports, Letter]
Arch Dermatol 2009 Sep; 145(9):1069-70.
Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19769527/full_citation/Mannosylated_nanoparticulate_carriers_of_rifabutin_for_alveolar_targeting_Nimje N, Agarwal A, Saraogi GK, et al. 
Mannosylated nanoparticulate carriers of rifabutin for alveolar targeting. [JOURNAL ARTICLE]
J Drug Target 2009 Sep 21.
Abstract | Full Citation | Find Related Articles